Low dialysate potassium and central arterial pressure waveform

Ups J Med Sci. 2015;120(3):207-12. doi: 10.3109/03009734.2015.1037031. Epub 2015 May 7.

Abstract

Background: Cardiovascular mortality is high in hemodialysis (HD) patients. Early arterial pressure wave reflections predict mortality in HD patients, and HD acutely improves the central pressure waveform. Potassium (K) plays a crucial role in cardiac electrophysiology, and patients with end-stage kidney disease depend on HD for neutral K balance. We aimed to study the impact of dialysate K concentrations on central arterial pressure waveform.

Methods: Thirty-three chronic HD patients were studied before and after a HD session, and the prescribed dialysate K concentration was recorded. In a subset of 23 patients without arrhythmias, pulse wave analysis was performed on radial arteries. Nine patients had dialysate K set to 1 mmol/L (group 1), and 14 patients had K set to 2 or 3 mmol/L (group 2). Augmentation index (AIx), defined as difference between the second and first systolic peak divided by central pulse pressure, was used as a measure of arterial stiffness.

Results: HD reduced the AIx in group 1 only (p = 0.0005). Likewise, central systolic pressure was reduced in group 1 only (p = 0.006). The relative reduction of AIx post-HD was significantly higher in group 1 compared with group 2 (p < 0.0001). The association between low dialysate K and AIx reduction remained statistically significant after adjustment for variables including the change in central and peripheral systolic pressure and mean arterial pressure.

Conclusion: Low dialysate K is strongly and independently associated with the acute improvement of AIx.

Keywords: central pressure augmentation; hemodialysis; potassium.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arterial Pressure / drug effects*
  • Arterial Pressure / physiology
  • Blood Pressure Determination
  • Female
  • Hemodialysis Solutions / chemistry
  • Hemodialysis Solutions / pharmacology*
  • Hemodialysis Solutions / therapeutic use
  • Humans
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Potassium / pharmacology*
  • Potassium / therapeutic use
  • Renal Dialysis*
  • Treatment Outcome

Substances

  • Hemodialysis Solutions
  • Potassium